Friday, January 29, 2016

FDA official says agency is making progress on generic drug backlog

FDA official says agency is making progress on generic drug backlog
The U.S. Senate Committee on Health, Education, Labor and Pensions heard testimony from Dr. Janet Woodcock, director of the FDA' s Center for Drug Evaluation and Research, who updated legislators on the progress of speeding up and improving the generic drug approval process.  READ MORE

No comments: